Thrombocyte aggregation inhibiting composition and methods

摘要

Platelet aggregation inhibiting compositions containing as active agent at least one compound selected from the group consisting of tetrahydroxyaporphine, glaucine containing 50 to 100% l-glaucine, and the physiologically acceptable salts and N-alkyl ammonium salts thereof are disclosed, as is a method for inhibiting platelet aggregation by administration of effective dosages of such compounds admixed with suitable carriers.